drugset / Trial / NCT04823845

Plantar Wart Treatment Using Adapalene Gel

NCT04823845

Phase 0 Withdrawn University of Louisville
NaSingle-groupOpen-labelTreatment

Summary

This study seeks to research the efficacy of Adapalene 0.1% gel as a cost effective and low risk treatment option for plantar warts of the foot. Patients that present/diagnosed in designated clinics with plantar warts will be offered the option of being treated with regular superficial debridements of the epidermis and twice a day application of adapalene gel 0.1% under occlusion. Patients will be followed until resolution.

Timeline

Start
2022-05-01
Primary completion
2022-12-10
Completion
2023-02-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.1 % Topical

Indications